# Phase 1 Study of VEGF Trap in Patients With Diabetic Macular Edema

> **NCT00320814** · PHASE1 · COMPLETED · sponsor: **Regeneron Pharmaceuticals** · enrollment: 5 (actual)

## Conditions studied

- Diabetic Macular Edema

## Interventions

- **DRUG:** VEGF Trap-Eye

## Key facts

- **NCT ID:** NCT00320814
- **Lead sponsor:** Regeneron Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2006-08
- **Final completion:** 2007-08
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2011-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00320814

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00320814, "Phase 1 Study of VEGF Trap in Patients With Diabetic Macular Edema". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00320814. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*